TUSTIN, CA--(Marketwire - November 22, 2010) - Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) announced today its business update, unaudited results and filing of its Form 10-Q with the Securities and Exchange Commission ("SEC") for the third quarter 2010.